SCHEMBL3779330

SCHEMBL3779330

Cc1ccc(S(=O)(=O)CP(C)(=O)C(C)(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
KMT2A Q03164 3/20 0.51
MEN1 O00255 1/20 0.51
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
GAA P10253 1/20 0.42
LMNA P02545 1/20 0.42
CTSK P43235 1/20 0.41
TP53 P04637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA5B Q9Y2D0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25763345 0.76 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1CYP3A4CYP2C9
SCHEMBL16346863 0.76 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1CYP3A4CYP2C9
SCHEMBL13010448 0.75 ALDH1A1 (0.40) ALDH1A1KMT2AMEN1CYP3A4CYP2C9
SCHEMBL16346612 0.73 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1CYP3A4CYP2C9
SCHEMBL9083678 0.73 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1CYP3A4CYP2C9
SCHEMBL9431880 0.72 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1CYP3A4CYP2C9
SCHEMBL507150 0.71 ALDH1A1 (0.71) ALDH1A1KMT2AMEN1CYP3A4CYP2C9
SCHEMBL18045689 0.71 ALDH1A1 (0.71) ALDH1A1KMT2AMEN1CYP3A4CYP2C9
SCHEMBL17030883 0.70 MCHR1 (0.51) ALDH1A1KMT2AMEN1CYP3A4CYP2C9
SCHEMBL1374250 0.70 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317866-A1 IMIDAZOLE GROUP-CONTAINING PHOSPHORUS COMPOUNDS BASF SE (DE) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317866-A1 IMIDAZOLE GROUP-CONTAINING PHOSPHORUS COMPOUNDS ITPA, PPIP5K2, IPMK ALDH1A1 4277/4885KMT2A 2838/4885MEN1 331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.